Stephen B Hanauer MD
Inflammatory Bowel Disease
Medical Director, Digestive Health Center, Northwestern University Feinberg School of Medicine
Join to View Full Profile
676 N Saint Clair StSte 650Chicago, IL 60611
Phone+1 312-695-5620
Fax+1 312-695-2310
Dr. Hanauer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Stephen Hanauer is a gastroenterologist in Chicago, IL and is affiliated with multiple hospitals in the area, including University of Chicago Medical Center and Northwestern Memorial Hospital. He received his medical degree from University of Illinois College of Medicine at Chicago and has been in practice 40 years. He specializes in inflammatory bowel disease and is experienced in general gastroenterology, inflammatory bowel disease, ulcerative colitis, and crohn's disease.
Education & Training
University of ChicagoFellowship, Gastroenterology, 1981 - 1982- University of ChicagoResidency, Internal Medicine, 1977 - 1981
University of Illinois College of MedicineClass of 1977
Certifications & Licensure
FL State Medical License 2024 - Present
IL State Medical License 1978 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification PowerChart (Clinical), Cerner Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification Northwestern Meaningful Use Data Warehouse Application for Eligible Providers, Northwestern University, 2013-2017
Clinical Trials
- A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease Start of enrollment: 2002 Apr 01
- Imuran Dosing in Crohn's Disease Study Start of enrollment: 2005 Jul 01
- High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease Start of enrollment: 2007 Jan 01
Publications & Presentations
PubMed
- Endoscopic Response to Subcutaneous Infliximab by Disease Location: A Post Hoc Analysis of the LIBERTY-CD Study.Bruce E Sands, Stefan Schreiber, Marla C Dubinsky, Geert D'Haens, Bincy P Abraham
Clinical Gastroenterology and Hepatology. 2026-04-01 - Recovery of response and long-term outcomes following loss of response and dose escalation of subcutaneous infliximab: a post hoc analysis of the LIBERTY-CD & LIBERTY-...Marla C Dubinsky, Stefan Schreiber, Andres J Yarur, Bruce E Sands, Stephen B Hanauer
Inflammatory Bowel Diseases. 2026-03-18 - Correlation between patient-determined inflammatory bowel disease severity and the inflammatory bowel disease severity index.Andrew Mark McCombie, Corey A Siegel, Stephen B Hanauer, Timothy McAuliffe, Jessica Salwen-Deremer
The New Zealand Medical Journal. 2026-03-13
Authored Content
- DDW 2025: Perspectives on IBDMay 2025
- The Elephant in the GI SystemJune 2024
- IBD Impressions from DDW 2022May 2022
Press Mentions
Colonoscopies: They Aren’t Fun, but Having One Could Save Your LifeFebruary 20th, 2025- Mindfulness, CBT Combo Improves Quality of Life in Crohn’sOctober 7th, 2024
- Subcutaneous Infliximab Beats Placebo for IBD Maintenance TherapySeptember 11th, 2024
Grant Support
- Multi-Site Trial Of Azathioprine Dosing In Crohn DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2004
- Multi-Site Trial Of Azathioprine Dosing In Crohn DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2003
- Anti-Tnfa MAB (Remicad /Infliximab) In Active Crohn'S DINational Center For Research Resources2000–2002
- Phase II Study Of Bxt 51072 In Patients W/ Ulcerative ColitisNational Center For Research Resources1999–2002
- Cdp571 In Steroid Dependent Patients W/ Crohns DiseaseNational Center For Research Resources1999–2002
Committees
- Chair, FDA Gastrointestinal Drugs Advisory Committee 2005 - Present
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
